160 related articles for article (PubMed ID: 11269538)
21. [Surgical treatment of lung carcinoma in tuberculosis patients].
Vencevicius V; Cicenas S; Miliauskas P
Medicina (Kaunas); 2004; 40(12):1170-4. PubMed ID: 15630343
[TBL] [Abstract][Full Text] [Related]
22. Bullous dermatomyositis: a marker of poor prognosis and aggressive internal malignancy?
Zangrilli A; Papoutsaki M; Bianchi L; Teoli M; Chimenti S
Acta Derm Venereol; 2008; 88(4):393-4. PubMed ID: 18709313
[No Abstract] [Full Text] [Related]
23. [Idiopathic inflammatory myopathies with anti-PM-Scl antibodies: case series and literature review].
Marie I; Lahaxe L; Tiev K; Duval-Modeste AB; Vittecoq O; Levesque H; Jouen F
Rev Med Interne; 2010 Aug; 31(8):540-4. PubMed ID: 20510485
[TBL] [Abstract][Full Text] [Related]
24. Opportunistic infections in polymyositis and dermatomyositis.
Marie I; Hachulla E; Chérin P; Hellot MF; Herson S; Levesque H; Hatron PY
Arthritis Rheum; 2005 Apr; 53(2):155-65. PubMed ID: 15818648
[TBL] [Abstract][Full Text] [Related]
25. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
Eymard B
Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
[TBL] [Abstract][Full Text] [Related]
26. Anti-NXP2-Positive Paraneoplastic Dermatomyositis With Histopathologic Changes Confined to the Acrosyringia.
Ramírez-Bellver JL; Macías E; Bernárdez C; López-Robles J; Vegas-Sánchez MD; Díaz-Recuero JL; Quiceno H; Requena L
Am J Dermatopathol; 2017 Jan; 39(1):e3-e7. PubMed ID: 28045754
[TBL] [Abstract][Full Text] [Related]
27. Features of polymyositis and dermatomyositis in the elderly: a case-control study.
Pautas E; Chérin P; Piette JC; Pelletier S; Wechsler B; Cabane J; Herson S
Clin Exp Rheumatol; 2000; 18(2):241-4. PubMed ID: 10812498
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
Hozumi H; Enomoto N; Kono M; Fujisawa T; Inui N; Nakamura Y; Sumikawa H; Johkoh T; Nakashima R; Imura Y; Mimori T; Suda T
PLoS One; 2015; 10(3):e0120313. PubMed ID: 25789468
[TBL] [Abstract][Full Text] [Related]
29. Polymyositis associated with urinary bladder cancer: an autopsy case.
Takeda I; Sugisaki K; Iwadate H; Kanno T; Odajima H; Kamimura K; Sakuma H; Endo H; Kasukawa R
Fukushima J Med Sci; 2004 Jun; 50(1):21-8. PubMed ID: 15536887
[TBL] [Abstract][Full Text] [Related]
30. [Polymyositis and dermatomyositis in esophageal cancer].
Mañas MD; Marchán E; Calderón P; Lara P
An Med Interna; 2007 May; 24(5):254-5. PubMed ID: 17929389
[No Abstract] [Full Text] [Related]
31. [Dermatomyositis as the first manifestation of small cell carcinoma: case report and literature review].
Ahumada Piña H; Fuentes Cabrera L; Selamé Glena R; García Oneto D; Jiménez Aguilar A; Durán Herrera C; Ávila Pérez J; Cortés Latorre M
Medwave; 2016 Nov; 16(10):e6609. PubMed ID: 27858925
[TBL] [Abstract][Full Text] [Related]
32. T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis.
Shimojima Y; Matsuda M; Ishii W; Kishida D; Sekijima Y
Autoimmunity; 2017 Dec; 50(8):481-490. PubMed ID: 29172719
[TBL] [Abstract][Full Text] [Related]
33. [Relationship between the onset and outcome of interstitial pneumonia associated with polymyositis and dermatomyositis].
Saku N; Ohno S; Sugiyama Y; Kitamura S
Nihon Kokyuki Gakkai Zasshi; 1998 Jul; 36(7):585-9. PubMed ID: 9805908
[TBL] [Abstract][Full Text] [Related]
34. A rare case of dermatomyositis associated with immune-complex type glomerulonephritis, idiopathic thrombopenic purpura, pulmonary fibrosis and lung cancer.
Kaneoka H; Sasatomi Y; Miyagi K; Kiyoshi Y; Takeda S; Takebayashi S; Naito S; Saito T
Clin Exp Rheumatol; 2003; 21(6):801-2. PubMed ID: 14740466
[No Abstract] [Full Text] [Related]
35. Paraneoplastic polymyositis associated with squamous cell carcinoma of the lung.
Gabrilovich M; Raza M; Dolan S; Raza T
Chest; 2006 Jun; 129(6):1721-3. PubMed ID: 16778295
[TBL] [Abstract][Full Text] [Related]
36. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
Fujisawa T; Hozumi H; Kono M; Enomoto N; Nakamura Y; Inui N; Nakashima R; Imura Y; Mimori T; Suda T
Respir Investig; 2017 Mar; 55(2):130-137. PubMed ID: 28274528
[TBL] [Abstract][Full Text] [Related]
37. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis.
Kang EH; Lee EB; Shin KC; Im CH; Chung DH; Han SK; Song YW
Rheumatology (Oxford); 2005 Oct; 44(10):1282-6. PubMed ID: 15972351
[TBL] [Abstract][Full Text] [Related]
38. Interstitial lung disease in polymyositis and dermatomyositis.
Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody.
Marie I; Lahaxe L; Benveniste O; Delavigne K; Adoue D; Mouthon L; Hachulla E; Constans J; Tiev K; Diot E; Levesque H; Boyer O; Jouen F
Br J Dermatol; 2010 Feb; 162(2):337-44. PubMed ID: 19845665
[TBL] [Abstract][Full Text] [Related]
40. [Purulent pleurisy and lung cancer. Non-iatrogenic forms and therapeutic management].
Riquet M; Hubsch JP; Le Pimpec Barthes F; Abitbol P; Souilamas R; Zukerman C; Manac'h D
Rev Mal Respir; 1999 Nov; 16(5):817-22. PubMed ID: 10612151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
